Sunday, December 24, 2017

(LML) Chemoprophylaxis in Leprosy

Leprosy Mailing List – December 24,  2017

Ref.:    (LML) Chemoprophylaxis in Leprosy

From:  Diana Lockwood, London, UK

Dear Pieter,

I and several other academics working in leprosy have concerns about the recommendation that single dose Rifampicin should be used as chemo-prophylaxis.  These concerns relate to efficacy, the ethics of household contact tracing, likely problems with compliance and the risk of promoting Rifampicin resistance in M. leprae

We have written to Erwin Cooreman, Head of the Global Leprosy Programme   and Anil Kumar the Head of the Indian Leprosy programme. We here share the letter with the Leprosy Mailing List. 

We are hoping for a useful discussion.

Best wishes,


Diana Lockwood

Professor of Tropical Medicine

London School of Hygiene & Tropical Medicine

Keppel St

London WC1E 7HT

Tel: 020 7927 2457

visit my blog


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<


No comments: